Yamamoto Y - Search Results

1

The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment.

Yamamoto Y, Yamauchi C, Toyama T, Nagai S, Sakai T, Kutomi G, Yoshimura M, Kawai M, Ohtani S, Kubota K, Nakashima K, Honma N, Yoshida M, Tokunaga E, Taira N, Iwata H, Saji S. Yamamoto Y, et al. Breast Cancer. 2024 May;31(3):340-346. doi: 10.1007/s12282-024-01566-6. Epub 2024 Apr 3. Breast Cancer. 2024. PMID: 38570435 Free PMC article.

2

Significance of serum carcinoembryonic antigen and CA 15-3 in monitoring advanced breast cancer patients treated with systemic therapy: a large-scale retrospective study.

Kurebayashi J, Yamamoto Y, Tanaka K, Kohno N, Kurosumi M, Moriya T, Nishimura R, Ogawa Y, Taguchi T; Tumor Marker Study Group of the Japanese Breast Cancer Society, Japan. Kurebayashi J, et al. Among authors: yamamoto y. Breast Cancer. 2003;10(1):38-44. doi: 10.1007/BF02967624. Breast Cancer. 2003. PMID: 12525762

3

Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues.

Yamamoto Y, Yamashita J, Toi M, Muta M, Nagai S, Hanai N, Furuya A, Osawa Y, Saji S, Ogawa M. Yamamoto Y, et al. Oncol Rep. 2003 Jul-Aug;10(4):791-6. Oncol Rep. 2003. PMID: 12792725

4

[Retrospective study on utility of irinotecan hydrochloride in patients with advanced and recurrent breast cancer].

Okubo S, Kurebayashi J, Sonoo H, Hirono M, Nomura N, Udagawa K, Yamamoto Y, Ikeda M, Nakashima K, Tanaka K. Okubo S, et al. Among authors: yamamoto y. Gan To Kagaku Ryoho. 2003 Oct;30(10):1441-5. Gan To Kagaku Ryoho. 2003. PMID: 14584275 Japanese.

5

Inhibition of HER1 signaling pathway enhances antitumor effect of endocrine therapy in breast cancer.

Kurebayashi J, Okubo S, Yamamoto Y, Sonoo H. Kurebayashi J, et al. Among authors: yamamoto y. Breast Cancer. 2004;11(1):38-41. doi: 10.1007/BF02968000. Breast Cancer. 2004. PMID: 14718791 Review.

6

[Retrospective analysis on efficacy and toxicity of paclitaxel-containing treatments in patients with advanced or recurrent breast cancer].

Hirono M, Kurebayashi J, Sonoo H, Nomura N, Okubo S, Udagawa K, Yamamoto Y, Ikeda M, Nakashima K, Tanaka K. Hirono M, et al. Among authors: yamamoto y. Gan To Kagaku Ryoho. 2004 May;31(5):723-7. Gan To Kagaku Ryoho. 2004. PMID: 15170980 Japanese.

7

A case report of paraneoplastic neurological syndrome associated with occult breast cancer.

Kawasoe T, Yamamoto Y, Okumura Y, Iwase H. Kawasoe T, et al. Among authors: yamamoto y. Breast Cancer. 2006;13(2):202-4. doi: 10.2325/jbcs.13.202. Breast Cancer. 2006. PMID: 16755118 Free article.

8

[Therapeutic efficacy of capecitabine on advanced and recurrent breast cancer with special reference to time to progression].

Shiiki S, Sonoo H, Seki M, Nomura T, Hironou M, Ookubo S, Udagawa K, Yamamoto Y, Nakashima K, Ikeda M, Tanaka K, Kurebayashi J. Shiiki S, et al. Among authors: yamamoto y. Gan To Kagaku Ryoho. 2006 Oct;33(10):1431-5. Gan To Kagaku Ryoho. 2006. PMID: 17033232 Japanese.

9

Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.

Zhang Z, Yamashita H, Toyama T, Yamamoto Y, Kawasoe T, Iwase H. Zhang Z, et al. Among authors: yamamoto y. Clin Cancer Res. 2006 Nov 1;12(21):6410-4. doi: 10.1158/1078-0432.CCR-06-1347. Clin Cancer Res. 2006. PMID: 17085653

10

[Docetaxel administration for radioiodine-resistant patients with metastatic papillary thyroid carcinoma].

Ikeda M, Tanaka K, Sonoo H, Miyake A, Yamamoto Y, Shiiki S, Nakashima K, Kurebayashi J. Ikeda M, et al. Among authors: yamamoto y. Gan To Kagaku Ryoho. 2007 Jun;34(6):933-6. Gan To Kagaku Ryoho. 2007. PMID: 17565260 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,994 results

Search Page